-
-
-
-
-
-
-
William Blair Reiterates Market Perform Rating on Maravai LifeScience Holdings Inc. (MRVI)
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action - Hagens Berman
-
-
-
-
-
-
-
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending - Hagens Berman
-
-
-
-
-
-
-
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman
-
-
-
-
-
-
-
Stock Alert: Maravai LifeSciences Holdings - Company Will Delay Earnings Release - Kehoe Law Firm, P.C. Investigating Potential Securities Claims - MRVI
-
-
-
-
-
-
-
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
-
1,180,395 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

